{"id":9337,"date":"2025-12-17T16:04:29","date_gmt":"2025-12-17T08:04:29","guid":{"rendered":"https:\/\/regask.com\/?p=9337"},"modified":"2025-12-17T16:04:29","modified_gmt":"2025-12-17T08:04:29","slug":"lue-annonce-une-reforme-historique-de-la-legislation-pharmaceutique","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/","title":{"rendered":"L\u2019UE annonce une r\u00e9forme historique de sa l\u00e9gislation pharmaceutique\u2026"},"content":{"rendered":"<p>Le 11 d\u00e9cembre 2025, <strong><a href=\"https:\/\/commission.europa.eu\/index_en\">Commission europ\u00e9enne<\/a> <\/strong>a annonc\u00e9 un accord politique sur un <strong>R\u00e9forme majeure de la l\u00e9gislation pharmaceutique de l&#039;UE<\/strong>, ce qui constitue la refonte la plus importante du cadre depuis plus de 20 ans. Cette mise \u00e0 jour affecte <strong>acteurs de l&#039;\u00e9cosyst\u00e8me pharmaceutique<\/strong>, notamment les fabricants, les organismes de r\u00e9glementation, les prestataires de soins de sant\u00e9 et les patients, et <strong>vise \u00e0 moderniser les r\u00e8gles afin d&#039;am\u00e9liorer l&#039;innovation, la s\u00e9curit\u00e9, l&#039;acc\u00e8s aux m\u00e9dicaments et la r\u00e9silience de l&#039;approvisionnement.<\/strong> L&#039;adoption formelle par le Parlement europ\u00e9en et le Conseil est toujours n\u00e9cessaire avant que les r\u00e9formes n&#039;entrent en vigueur.<\/p>\n<div class=\"row\"  id=\"row-962389118\">\n\n\t<div id=\"col-2020601189\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-377378666\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-377378666 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2><span class=\"TextRun MacChromeBold SCXW150983442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW150983442 BCX0\" data-ccp-parastyle=\"heading 3\">Qu\u2019est-ce qui change dans le cadre pharmaceutique de l\u2019UE\u00a0?<\/span><\/span><span class=\"EOP SCXW150983442 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h2>\n\t<div id=\"gap-1611480411\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1611480411 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Cette r\u00e9forme met \u00e0 jour les r\u00e8gles pharmaceutiques de l&#039;UE, en vigueur depuis longtemps, afin de mieux refl\u00e9ter les r\u00e9alit\u00e9s scientifiques, num\u00e9riques et de la cha\u00eene d&#039;approvisionnement actuelles.<\/p>\n<p>Il introduit <strong>proc\u00e9dures r\u00e9glementaires simplifi\u00e9es<\/strong> visant \u00e0 r\u00e9duire les d\u00e9lais d&#039;\u00e9valuation pour les deux <strong>nouveaux m\u00e9dicaments et m\u00e9dicaments g\u00e9n\u00e9riques,<\/strong> justificatif <a href=\"https:\/\/regask.com\/fr\/classification-des-produits-entree-sur-le-marche\/\">entr\u00e9e plus rapide sur le march\u00e9<\/a> tout en maintenant les normes de s\u00e9curit\u00e9 des patients.<\/p>\n<p>L&#039;accord introduit \u00e9galement <strong>bacs \u00e0 sable r\u00e9glementaires,<\/strong> Ces environnements contr\u00f4l\u00e9s permettent de tester en toute s\u00e9curit\u00e9 des th\u00e9rapies innovantes sous la supervision des autorit\u00e9s r\u00e9glementaires. Ces laboratoires d&#039;exp\u00e9rimentation sont con\u00e7us pour favoriser l&#039;innovation tout en garantissant le respect des exigences de s\u00e9curit\u00e9 et de qualit\u00e9.<\/p>\n<p>Pour rem\u00e9dier aux difficult\u00e9s d&#039;approvisionnement persistantes, la r\u00e9forme \u00e9tablit une approche renforc\u00e9e en mati\u00e8re de pr\u00e9vention et de surveillance des p\u00e9nuries, notamment\u00a0:<\/p>\n<ul>\n<li>Un nouveau <strong>Cadre europ\u00e9en de surveillance des p\u00e9nuries de m\u00e9dicaments\u00a0<\/strong><\/li>\n<li>Des obligations renforc\u00e9es pour les entreprises<\/li>\n<li>Coordination am\u00e9lior\u00e9e gr\u00e2ce \u00e0 <a href=\"https:\/\/www.ema.europa.eu\/en\/homepage\"><strong>Agence europ\u00e9enne des m\u00e9dicaments (EMA)<\/strong><\/a><\/li>\n<\/ul>\n<p>Parall\u00e8lement, l&#039;UE \u00e9tablira un <strong>liste des m\u00e9dicaments essentiels,<\/strong> appuy\u00e9es par des \u00e9valuations de vuln\u00e9rabilit\u00e9 permettant d&#039;identifier et d&#039;att\u00e9nuer les risques li\u00e9s \u00e0 l&#039;approvisionnement.<\/p>\n<p>La r\u00e9forme clarifie davantage l&#039;application de <strong>Exemption Bolar,<\/strong> permettre aux fabricants de g\u00e9n\u00e9riques de pr\u00e9parer leur entr\u00e9e sur le march\u00e9 avant l&#039;expiration du brevet et favoriser un acc\u00e8s rapide \u00e0 des m\u00e9dicaments abordables.<\/p>\n<p>En outre, <strong>nouvelles incitations<\/strong> sont introduits pour les produits innovants qui r\u00e9pondent <strong>besoins m\u00e9dicaux non satisfaits,<\/strong> renforcer l&#039;ambition de l&#039;UE de rester comp\u00e9titive en mati\u00e8re d&#039;innovation pharmaceutique.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-2020601189 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1572456419\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pourquoi c&#039;est important<\/h2>\n\t<div id=\"gap-748945301\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-748945301 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Cette r\u00e9forme offre une plus grande marge de man\u0153uvre <strong>clart\u00e9 r\u00e9glementaire,<\/strong> harmonise la l\u00e9gislation pharmaceutique avec <strong>innovation moderne et d\u00e9veloppement num\u00e9rique,<\/strong> et am\u00e9liore <strong>efficacit\u00e9 r\u00e9glementaire<\/strong> sans alourdir inutilement les charges administratives. En renfor\u00e7ant le contr\u00f4le de la cha\u00eene d&#039;approvisionnement et en acc\u00e9l\u00e9rant l&#039;acc\u00e8s aux m\u00e9dicaments, ce cadre vise \u00e0 am\u00e9liorer la s\u00e9curit\u00e9 des patients et la r\u00e9silience du syst\u00e8me dans toute l&#039;UE.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1572456419 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1241613551\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>\u00c0 qui s&#039;adresse cette mise \u00e0 jour<\/h2>\n\t<div id=\"gap-418354057\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-418354057 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Cette mise \u00e0 jour est pertinente pour <strong>Affaires r\u00e9glementaires, assurance qualit\u00e9, cha\u00eene d&#039;approvisionnement, acc\u00e8s au march\u00e9, recherche et d\u00e9veloppement, <\/strong>et<strong> \u00c9quipes de conformit\u00e9,<\/strong> ainsi que <strong>\u00e9quipes informatiques et de donn\u00e9es<\/strong> soutenir les op\u00e9rations r\u00e9glementaires et les obligations de surveillance des p\u00e9nuries au sein des organisations pharmaceutiques.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1241613551 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-633761662\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Prochaines \u00e9tapes<\/h2>\n\t<div id=\"gap-848696916\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-848696916 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Les parties prenantes devraient :<\/p>\n<ul>\n<li><strong>Examiner les portefeuilles de produits en cours, les strat\u00e9gies r\u00e9glementaires et les pratiques de la cha\u00eene d&#039;approvisionnement<\/strong> \u00e9valuer la conformit\u00e9 avec les proc\u00e9dures simplifi\u00e9es propos\u00e9es et les exigences de surveillance des p\u00e9nuries<\/li>\n<li><strong>Suivre le processus d&#039;approbation officiel<\/strong> au Parlement europ\u00e9en et au Conseil<\/li>\n<li>Pr\u00e9parez-vous \u00e0 adapter vos strat\u00e9gies de conformit\u00e9 une fois que les obligations et les incitations d\u00e9finitives seront confirm\u00e9es.<\/li>\n<li>Alors que les organisations se pr\u00e9parent \u00e0 ces changements \u00e0 venir, il devient de plus en plus important pour elles de disposer d&#039;une visibilit\u00e9 structur\u00e9e sur l&#039;\u00e9volution de la r\u00e9glementation pharmaceutique de l&#039;UE.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/regask.com\/fr\/\"><strong>RegASK<\/strong><\/a> <strong>est une plateforme de pointe d&#039;intelligence r\u00e9glementaire et d&#039;orchestration des flux de travail bas\u00e9e sur l&#039;IA agentielle<\/strong> qui permet aux organisations internationales op\u00e9rant dans des secteurs fortement r\u00e9glement\u00e9s, notamment les produits de consommation et les sciences de la vie, de s&#039;orienter de mani\u00e8re proactive dans des environnements r\u00e9glementaires complexes. En combinant des technologies de pointe <strong><a href=\"https:\/\/regask.com\/fr\/quest-ce-que-lia-agentique-dans-le-domaine-de-lintelligence-de-conformite-reglementaire\/\">IA agentique<\/a> <\/strong>Gr\u00e2ce \u00e0 l&#039;expertise de ses utilisateurs, RegASK fournit des informations pr\u00e9dictives exploitables en temps opportun et une automatisation de bout en bout, rationalisant les processus de conformit\u00e9, att\u00e9nuant les risques et acc\u00e9l\u00e9rant l&#039;acc\u00e8s au march\u00e9. <strong>Plus de 157 pays.\u00a0\u00a0<\/strong><\/p>\n<p><a href=\"https:\/\/regask.com\/fr\/produit\/\"><strong>En savoir plus<\/strong><\/a> ou <strong><a href=\"https:\/\/regask.com\/fr\/reserver-une-demo\/\">r\u00e9servez une d\u00e9mo maintenant.\u00a0<\/a><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-633761662 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-1569033722\">\n\n\t<div id=\"col-178629352\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>FAQ<\/h3>\n\t<div id=\"gap-32712471\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-32712471 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4>Qu\u2019a annonc\u00e9 la Commission europ\u00e9enne le 11 d\u00e9cembre 2025\u00a0?<\/h4>\n\t<div id=\"gap-1455555748\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1455555748 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>La Commission europ\u00e9enne a annonc\u00e9<strong>accord politique sur une r\u00e9forme majeure de la l\u00e9gislation pharmaceutique de l&#039;UE,<\/strong> visant \u00e0 moderniser des r\u00e8gles datant de plus de 20 ans.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-178629352 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1341911180\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>Quels sont les principaux objectifs de la r\u00e9forme pharmaceutique de l&#039;UE\u00a0?<\/h4>\n\t<div id=\"gap-1961020873\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1961020873 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>La r\u00e9forme vise \u00e0 <strong>\u00e9largir l&#039;acc\u00e8s aux m\u00e9dicaments, rationaliser les processus r\u00e9glementaires,<\/strong> <strong>rem\u00e9dier aux p\u00e9nuries de m\u00e9dicaments, am\u00e9liorer la s\u00e9curit\u00e9 des patients et soutenir l&#039;innovation pharmaceutique.<\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1341911180 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1713384890\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>Comment cette r\u00e9forme rem\u00e9die-t-elle aux p\u00e9nuries de m\u00e9dicaments dans l&#039;UE\u00a0?<\/h4>\n\t<div id=\"gap-1111861367\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1111861367 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Il introduit un <strong>Cadre de l&#039;UE pour le suivi des p\u00e9nuries de m\u00e9dicaments,<\/strong> renforce les obligations de l&#039;entreprise, am\u00e9liore <strong>Coordination de l&#039;EMA,<\/strong> et \u00e9tablit un <strong>liste des m\u00e9dicaments essentiels<\/strong> avec des \u00e9valuations de vuln\u00e9rabilit\u00e9.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1713384890 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-506343727\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>Comment le programme RegASK peut-il aider les \u00e9quipes \u00e0 g\u00e9rer l&#039;impact de ces changements pharmaceutiques au niveau de l&#039;UE\u00a0?<\/h4>\n\t<div id=\"gap-1174269953\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1174269953 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><a href=\"https:\/\/regask.com\/fr\/\">RegASK<\/a> aide les \u00e9quipes r\u00e9glementaires et de conformit\u00e9 <strong>surveiller l&#039;\u00e9volution de la r\u00e9glementation, \u00e9valuer son impact sur les produits et les cha\u00eenes d&#039;approvisionnement, et mettre en \u0153uvre les mises \u00e0 jour r\u00e9glementaires.<\/strong> gr\u00e2ce \u00e0 l&#039;intelligence artificielle et \u00e0 l&#039;automatisation des flux de travail.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-506343727 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Le 11 d\u00e9cembre 2025, la Commission europ\u00e9enne a annonc\u00e9 un accord politique sur une r\u00e9forme majeure de la l\u00e9gislation pharmaceutique de l&#039;UE, marquant la refonte la plus importante de ce cadre depuis plus de 20 ans. Cette mise \u00e0 jour concerne tous les acteurs de l&#039;\u00e9cosyst\u00e8me pharmaceutique, notamment les fabricants, les autorit\u00e9s r\u00e9glementaires, les professionnels de sant\u00e9 et les patients, et vise \u00e0 moderniser les r\u00e8gles afin d&#039;am\u00e9liorer l&#039;innovation, la s\u00e9curit\u00e9\u2026<\/p>","protected":false},"author":41,"featured_media":9339,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,35],"tags":[],"class_list":["post-9337","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-pharma-biotech-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>EU Announces Landmark Reform of Pharmaceutical Regulations<\/title>\n<meta name=\"description\" content=\"The EU announces landmark reform of pharmaceutical legislation to enhance safety and access to medicines for all stakeholders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/lue-annonce-une-reforme-historique-de-la-legislation-pharmaceutique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU Announces Landmark Reform of Pharmaceutical Legislation\" \/>\n<meta property=\"og:description\" content=\"The EU announces landmark reform of pharmaceutical legislation to enhance safety and access to medicines for all stakeholders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/lue-annonce-une-reforme-historique-de-la-legislation-pharmaceutique\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-17T08:04:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shaffa Renaningtyas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaffa Renaningtyas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\"},\"author\":{\"name\":\"Shaffa Renaningtyas\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\"},\"headline\":\"EU Announces Landmark Reform of Pharmaceutical Legislat&hellip;\",\"datePublished\":\"2025-12-17T08:04:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\"},\"wordCount\":798,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/eu-announces-landmark-reform-pharmaceutical-legislation.png\",\"articleSection\":[\"Regulatory News\",\"Pharma and Biotech\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\",\"name\":\"EU Announces Landmark Reform of Pharmaceutical Regulations\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/eu-announces-landmark-reform-pharmaceutical-legislation.png\",\"datePublished\":\"2025-12-17T08:04:29+00:00\",\"description\":\"The EU announces landmark reform of pharmaceutical legislation to enhance safety and access to medicines for all stakeholders.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/eu-announces-landmark-reform-pharmaceutical-legislation.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/eu-announces-landmark-reform-pharmaceutical-legislation.png\",\"width\":800,\"height\":600,\"caption\":\"Eu Announces Landmark Reform Pharmaceutical Legislation\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\",\"name\":\"Shaffa Renaningtyas\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"L&#039;UE annonce une r\u00e9forme historique de la r\u00e9glementation pharmaceutique","description":"L\u2019UE annonce une r\u00e9forme historique de la l\u00e9gislation pharmaceutique visant \u00e0 am\u00e9liorer la s\u00e9curit\u00e9 et l\u2019acc\u00e8s aux m\u00e9dicaments pour toutes les parties prenantes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/lue-annonce-une-reforme-historique-de-la-legislation-pharmaceutique\/","og_locale":"fr_FR","og_type":"article","og_title":"EU Announces Landmark Reform of Pharmaceutical Legislation","og_description":"The EU announces landmark reform of pharmaceutical legislation to enhance safety and access to medicines for all stakeholders.","og_url":"https:\/\/regask.com\/fr\/lue-annonce-une-reforme-historique-de-la-legislation-pharmaceutique\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-12-17T08:04:29+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","type":"image\/png"}],"author":"Shaffa Renaningtyas","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Shaffa Renaningtyas","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#article","isPartOf":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/"},"author":{"name":"Shaffa Renaningtyas","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6"},"headline":"EU Announces Landmark Reform of Pharmaceutical Legislat&hellip;","datePublished":"2025-12-17T08:04:29+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/"},"wordCount":798,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","articleSection":["Regulatory News","Pharma and Biotech"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/","url":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/","name":"L&#039;UE annonce une r\u00e9forme historique de la r\u00e9glementation pharmaceutique","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","datePublished":"2025-12-17T08:04:29+00:00","description":"L\u2019UE annonce une r\u00e9forme historique de la l\u00e9gislation pharmaceutique visant \u00e0 am\u00e9liorer la s\u00e9curit\u00e9 et l\u2019acc\u00e8s aux m\u00e9dicaments pour toutes les parties prenantes.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","width":800,"height":600,"caption":"Eu Announces Landmark Reform Pharmaceutical Legislation"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Favoriser des d\u00e9cisions r\u00e9glementaires plus intelligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6","name":"Shaffa Renaningtyas"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/9337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=9337"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/9337\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/9339"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=9337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=9337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=9337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}